Clearwater Analytics (NYSE: CWAN) agreed to acquire Enfusion (NYSE: ENFN), a SaaS provider for hedge funds and investment managers, in a cash-and-stock deal valued at $1.5 billion.
Why it matters: The deal combines Clearwater's middle- and back-office tools with Enfusion's front-office product, creating an end-to-end platform.
